IPP Bureau
OncoSil secures TGA approval for pancreatic cancer device
By IPP Bureau - May 22, 2026
Approval of device in Australia for treating locally advanced pancreatic cancer alongside gemcitabine-based chemotherapy
Eli Lilly appoints Chandan S.as Senior Director for Data Science and AI Engineering
By IPP Bureau - May 22, 2026
AI and analytics leader brings extensive expertise in machine learning, GenAI, and life sciences decision intelligence to Lilly’s data science operations
Alembic Pharma elevates Karunanithi Ponnusamy as President of Animal Health Business
By IPP Bureau - May 22, 2026
Pharma veteran with over three decades of industry experience to lead Alembic’s animal health growth and market expansion initiatives.
Reliance Life Sciences appoints Siva Sankar Mahamkali as VP Biosimilars Manufacturing Operations
By IPP Bureau - May 22, 2026
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
Dr. Amit Arora joins Curelo as Co-founder & COO
By IPP Bureau - May 22, 2026
Diagnostic-guided healthcare platform strengthens leadership team to accelerate AI-driven diagnostics and consumer healthcare expansion
Aurobindo Pharma Q4 FY26 revenue rises 5.6% to Rs. 8,853 crore
By IPP Bureau - May 22, 2026
Net profit stood at Rs. 921 crore for the quarter, while Europe revenues surged 30.2% YoY to Rs. 2,795 crore
Dr. Agarwal’s Health Care crosses Rs.2,000 crore revenue milestone in FY26
By IPP Bureau - May 22, 2026
Eye care major expands network to 288 facilities across 10 countries after adding 57 new centres during FY26
IOLCP revenue rises 11.5% YoY to Rs. 2,319.1 crore in FY26
By IPP Bureau - May 21, 2026
Company’s EBITDA grew 29.3 per cent to Rs. 290.4 crore, while PAT rose 36.4 per cent to Rs. 137.7 crore
Takeda Pharma ordered to pay $2.5 billion in Amitiza case
By IPP Bureau - May 21, 2026
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Boehringer Ingelheim India signs MoUs with NIPER Ahmedabad and Hyderabad to expand research collaboration
By IPP Bureau - May 21, 2026
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
Eris Lifesciences reports Q4 FY26 revenue of Rs. 757 crore; PAT jumps 173%
By IPP Bureau - May 21, 2026
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
Apollo, Cloudnine merge maternity and fertility businesses in Rs. 1,550 crore deal
By IPP Bureau - May 21, 2026
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
QIAGEN and NVIDIA partner on AI drug discovery
By IPP Bureau - May 21, 2026
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases
Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in €115 million deal
By IPP Bureau - May 21, 2026
SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
India reaffirms commitment to global women and child health agenda at WHA 2026
By IPP Bureau - May 21, 2026
Minister J.P. Nadda holds bilateral meeting with Helen Clark, Board Chair of the Partnership for Maternal, Newborn and Child Health in Geneva
